This post was first published on 2nd September, 2014. Inventive step / Non-Obviousness is one of the most important patentability criteria in almost all patent jurisdictions. Non-obviousness...
Read more about From Dress Pin to Safety PinTag: Inventive Step
Patentability and Section 3(d), History of Patent Law in India, Patentability of Imatinib Masylate in Beta Crystalline Form – Novartis Case Abridged by Dr. Kalyan C. Kankanala
This abridged version of the Novartis case was used by Dr. Kalyan C. Kankanala to explain to the students of UPES, the patentability requirements under the...
Read more about Patentability and Section 3(d), History of Patent Law in India, Patentability of Imatinib Masylate in Beta Crystalline Form – Novartis Case Abridged by Dr. Kalyan C. KankanalaAnalyzing Patentability of Inventions – A Presentation by Dr. Kalyan C. Kankanala at the UPES School of Law
This presentation is part of the 'Patent Law and Practice Program' being taught by BananaIP Team at UPES School of Law to B.tech-LLB Students. This...
Read more about Analyzing Patentability of Inventions – A Presentation by Dr. Kalyan C. Kankanala at the UPES School of LawPatent News
Hello Readers!! There has been a lot that has been brewing over the past few weeks with respect to Patents. We have decided to recapitulate...
Read more about Patent NewsPatent Law in India- PPT on Patentability Requirements by Dr. Kalyan C. Kankanala at NLSIU
This presentation was delivered by Dr. Kalyan C. Kankanala at NLSIU, Bangalore, India, as a part of the Patent law course offered for PGDIP students....
Read more about Patent Law in India- PPT on Patentability Requirements by Dr. Kalyan C. Kankanala at NLSIUMerck v. Glenmark – A Bitter Battle of Pills
The Delhi High Court has restrained Glenmark from making and marketing generic versions of Merck Sharp & Dohme (MSD)'s popular antidiabetic drug “Januvia” (sitagliptin)...
Read more about Merck v. Glenmark – A Bitter Battle of PillsSpecial 301 Report: Chapter V. Inventive Step & 3(d) – Comprehending Apprehension or Apprehending Comprehension?
This post critically examines whether Section 3d serves as an extension of the inventive step analysis or as a separate requirement under Indian patent law. It discusses the legal and judicial perspectives on TRIPs compliance and the nuanced challenges in pharmaceutical patentability.
Read more about Special 301 Report: Chapter V. Inventive Step & 3(d) – Comprehending Apprehension or Apprehending Comprehension?